Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.

<h4>Background</h4>Early detection of melanoma is of great importance to reduce mortality. Discovering new melanoma biomarkers would improve early detection and diagnosis. Here, we present a novel approach to detect volatile compounds from skin.<h4>Methods and findings</h4>We...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatjana Abaffy, Robert Duncan, Daniel D Riemer, Olaf Tietje, George Elgart, Clara Milikowski, R Anthony DeFazio
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-11-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0013813&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850133754493796352
author Tatjana Abaffy
Robert Duncan
Daniel D Riemer
Olaf Tietje
George Elgart
Clara Milikowski
R Anthony DeFazio
author_facet Tatjana Abaffy
Robert Duncan
Daniel D Riemer
Olaf Tietje
George Elgart
Clara Milikowski
R Anthony DeFazio
author_sort Tatjana Abaffy
collection DOAJ
description <h4>Background</h4>Early detection of melanoma is of great importance to reduce mortality. Discovering new melanoma biomarkers would improve early detection and diagnosis. Here, we present a novel approach to detect volatile compounds from skin.<h4>Methods and findings</h4>We used Head Space Solid Phase Micro-Extraction (HS-SPME) and gas chromatography/mass spectrometry (GC/MS) to identify volatile signatures from melanoma, naevi and skin samples. We hypothesized that the metabolic state of tissue alters the profile of volatile compounds. Volatiles released from fresh biopsy tissue of melanoma and benign naevus were compared based on their difference in frequency distribution and their expression level. We also analyzed volatile profiles from frozen tissue, including skin and melanoma.<h4>Conclusions</h4>Three volatiles, 4-methyl decane, dodecane and undecane were preferentially expressed in both fresh and frozen melanoma, indicating that they are candidate biomarkers. Twelve candidate biomarkers evaluated by fuzzy logic analysis of frozen samples distinguished melanoma from skin with 89% sensitivity and 90% specificity. Our results demonstrate proof-of-principle that there is differential expression of volatiles in melanoma. Our volatile metabolomic approach will lead to a better understanding of melanoma and can enable development of new diagnostic and treatment strategies based on altered metabolism.
format Article
id doaj-art-7cf98ec6a7344964b7bfb012734303ec
institution OA Journals
issn 1932-6203
language English
publishDate 2010-11-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-7cf98ec6a7344964b7bfb012734303ec2025-08-20T02:31:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-11-01511e1381310.1371/journal.pone.0013813Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.Tatjana AbaffyRobert DuncanDaniel D RiemerOlaf TietjeGeorge ElgartClara MilikowskiR Anthony DeFazio<h4>Background</h4>Early detection of melanoma is of great importance to reduce mortality. Discovering new melanoma biomarkers would improve early detection and diagnosis. Here, we present a novel approach to detect volatile compounds from skin.<h4>Methods and findings</h4>We used Head Space Solid Phase Micro-Extraction (HS-SPME) and gas chromatography/mass spectrometry (GC/MS) to identify volatile signatures from melanoma, naevi and skin samples. We hypothesized that the metabolic state of tissue alters the profile of volatile compounds. Volatiles released from fresh biopsy tissue of melanoma and benign naevus were compared based on their difference in frequency distribution and their expression level. We also analyzed volatile profiles from frozen tissue, including skin and melanoma.<h4>Conclusions</h4>Three volatiles, 4-methyl decane, dodecane and undecane were preferentially expressed in both fresh and frozen melanoma, indicating that they are candidate biomarkers. Twelve candidate biomarkers evaluated by fuzzy logic analysis of frozen samples distinguished melanoma from skin with 89% sensitivity and 90% specificity. Our results demonstrate proof-of-principle that there is differential expression of volatiles in melanoma. Our volatile metabolomic approach will lead to a better understanding of melanoma and can enable development of new diagnostic and treatment strategies based on altered metabolism.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0013813&type=printable
spellingShingle Tatjana Abaffy
Robert Duncan
Daniel D Riemer
Olaf Tietje
George Elgart
Clara Milikowski
R Anthony DeFazio
Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
PLoS ONE
title Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
title_full Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
title_fullStr Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
title_full_unstemmed Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
title_short Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.
title_sort differential volatile signatures from skin naevi and melanoma a novel approach to detect a pathological process
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0013813&type=printable
work_keys_str_mv AT tatjanaabaffy differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess
AT robertduncan differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess
AT danieldriemer differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess
AT olaftietje differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess
AT georgeelgart differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess
AT claramilikowski differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess
AT ranthonydefazio differentialvolatilesignaturesfromskinnaeviandmelanomaanovelapproachtodetectapathologicalprocess